IBL HealthCare Past Earnings Performance
Past criteria checks 2/6
IBL HealthCare has been growing earnings at an average annual rate of 13.2%, while the Healthcare industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 17.5% per year. IBL HealthCare's return on equity is 9.7%, and it has net margins of 5.3%.
Key information
13.2%
Earnings growth rate
13.2%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 17.5% |
| Return on equity | 9.7% |
| Net Margin | 5.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How IBL HealthCare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,199 | 222 | 977 | 0 |
| 31 Dec 23 | 4,081 | 269 | 861 | 0 |
| 30 Sep 23 | 4,090 | 304 | 759 | 0 |
| 30 Jun 23 | 4,028 | 309 | 723 | 0 |
| 31 Mar 23 | 3,989 | 318 | 745 | 0 |
| 31 Dec 22 | 3,904 | 300 | 695 | 0 |
| 30 Sep 22 | 3,838 | 295 | 709 | 0 |
| 30 Jun 22 | 3,651 | 303 | 681 | 0 |
| 31 Mar 22 | 3,436 | 318 | 681 | 0 |
| 31 Dec 21 | 3,341 | 350 | 677 | 0 |
| 30 Sep 21 | 3,102 | 330 | 644 | 0 |
| 30 Jun 21 | 3,004 | 300 | 612 | 0 |
| 31 Mar 21 | 2,941 | 302 | 561 | 0 |
| 31 Dec 20 | 2,856 | 258 | 519 | 0 |
| 30 Sep 20 | 2,762 | 236 | 511 | 0 |
| 30 Jun 20 | 2,665 | 220 | 508 | 0 |
| 31 Mar 20 | 2,402 | 192 | 442 | 0 |
| 31 Dec 19 | 2,074 | 146 | 395 | 0 |
| 30 Sep 19 | 1,849 | 134 | 335 | 0 |
| 30 Jun 19 | 1,585 | 121 | 278 | 0 |
| 31 Mar 19 | 1,518 | 119 | 275 | 0 |
| 31 Dec 18 | 1,469 | 137 | 269 | 0 |
| 30 Sep 18 | 1,392 | 127 | 252 | 0 |
| 30 Jun 18 | 1,358 | 149 | 240 | 0 |
| 31 Mar 18 | 1,287 | 162 | 225 | 0 |
| 31 Dec 17 | 1,241 | 174 | 208 | 0 |
| 30 Sep 17 | 1,207 | 199 | 191 | 0 |
| 30 Jun 17 | 1,190 | 198 | 192 | 0 |
| 31 Mar 17 | 1,172 | 194 | 184 | 0 |
| 31 Dec 16 | 1,146 | 178 | 177 | 0 |
| 30 Sep 16 | 1,166 | 180 | 179 | 0 |
| 30 Jun 16 | 1,156 | 179 | 175 | 0 |
| 31 Mar 16 | 1,108 | 167 | 177 | 0 |
| 31 Dec 15 | 1,051 | 165 | 176 | 0 |
| 30 Sep 15 | 934 | 134 | 174 | 0 |
| 30 Jun 15 | 932 | 166 | 164 | 0 |
| 31 Mar 15 | 903 | 155 | 150 | 0 |
| 31 Dec 14 | 906 | 162 | 148 | 0 |
| 30 Sep 14 | 955 | 182 | 136 | 0 |
| 30 Jun 14 | 910 | 149 | 129 | 0 |
| 31 Mar 14 | 915 | 157 | 125 | 0 |
| 31 Dec 13 | 912 | 144 | 116 | 0 |
| 30 Sep 13 | 914 | 124 | 114 | 0 |
| 30 Jun 13 | 864 | 101 | 108 | 0 |
Quality Earnings: IBLHL has high quality earnings.
Growing Profit Margin: IBLHL's current net profit margins (5.3%) are lower than last year (8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IBLHL's earnings have grown by 13.2% per year over the past 5 years.
Accelerating Growth: IBLHL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IBLHL had negative earnings growth (-30.1%) over the past year, making it difficult to compare to the Healthcare industry average (3.4%).
Return on Equity
High ROE: IBLHL's Return on Equity (9.7%) is considered low.